COVID-19
In partnership with Arcturus Therapeutics, a world late-stage scientific mRNA medicines and vaccines firm, CSL obtained approval by Japan’s Ministry of Well being, Labor and Welfare (MHLW), for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine for preliminary vaccination and booster for adults 18 years and older in Japan. With the approval of ARCT-154, CSL now … Read more